They found ERG immunopositivity in 15 of 16 (94%) acute myeloid leukemias/myeloid sarcomas, including four out of five (80%) CD34-negative/CD117-negative acute myeloid leukemias/myeloid sarcomas. This evidence concerns the gene CD34 and acute myeloid leukemia.